Are electronic consents legally valid?

Yes. Electronic signatures are legally recognized under the federal ESIGN Act (15 U.S.C. §7001) and by state UETA statutes in most jurisdictions; ensure the signature shows intent, consent, attribution, and retention capability.

Do I need a HIPAA BAA for eConsent vendors?

If the vendor will access or store protected health information, execute a Business Associate Agreement as required by HIPAA; HIPAA policies and retention rules (45 CFR §164.530(j)) still apply.

What authentication is sufficient?

Authentication should match the risk: email link or SMS may be acceptable for low risk; consider stronger methods (KBA, multi-factor) for higher-risk studies or per IRB requirements.

Can forms be notarized remotely?

Remote notarization depends on state RON laws; many states permit RON with identity proofing and audio-video recording, but verify the state's notary rules before relying on RON for clinical consents.

How do I correct a signed form?

Do not alter a signed record. Create an addendum or corrected version with new signatures and date; retain the original for audit and note the reason for correction.

How long must signed consents be kept?

Retain consent forms for the life of the trial and follow federal and HIPAA retention rules; HIPAA requires 6 years (45 CFR §164.530(j)) and some sponsors or states require longer periods.

Electronic Signature
Templates
Healthcare
Healthcare Clinical Trials Form

Healthcare Clinical Trials Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CLINICAL TRIALS FORM

Study Identification

Study Title Protocol Number Principal Investigator Study Site / Clinic

Participant Information

Full Legal Name Date of Birth Gender

Male Female Other / Prefer not to say

Home Address Phone Emergency Contact

Insurance & Financial

Primary Insurance Provider Policy / ID Number Subscriber Name (if different)

Medical History

Current Medications Allergies (including drug allergies) Prior Surgeries / Hospitalizations Chronic Conditions / Diagnoses

Are you currently pregnant, breastfeeding, or planning pregnancy during the study period? Yes No

Study Procedures, Risks & Benefits

Purpose of Study: The purpose of this clinical trial is to evaluate the safety and efficacy of the investigational intervention described above. Participation involves procedures described in the study protocol, including screening, baseline assessments, scheduled visits, laboratory testing, imaging, medication administration, and follow-up evaluations.

Planned Procedures (summary)

Risks and Discomforts: Participation may involve foreseeable risks, which can include but are not limited to adverse reactions, pain at injection or blood draw sites, allergic reactions, changes in laboratory values, or other unanticipated health effects. The investigator will explain known significant risks and safety monitoring procedures prior to enrollment.

Potential Benefits: There may be no direct medical benefit to you. Potential benefits include clinical monitoring and the possibility that the investigational intervention may help your condition. Any potential benefits are not guaranteed.

Alternatives, Compensation & Costs

Alternatives: You may choose not to participate or may choose other approved therapies or standard medical care as alternatives to participation in this study.

Compensation and Reimbursement: You will be informed of any compensation, travel reimbursement, or other payments for participation. Specific payment terms (if any) will be provided below.

Compensation / Reimbursement Details

Privacy, Data Use & Authorization

Confidentiality: Reasonable efforts will be made to keep your study records confidential. Personal health information necessary for the research and monitoring will be collected and may be reviewed by the sponsor, regulatory authorities, and institutional review board. Identifiable information will be handled in accordance with applicable privacy protections and the study's data management plan.

Use of Biological Samples: You will be asked whether you consent to collection, storage, and future research use of biological specimens, including genetic analysis. You may decline sample storage and still participate in the main study unless sample collection is required for safety.

Please indicate your authorization choices:

I consent to collection and long-term storage of biological specimens for future research. I consent to genetic analysis of collected specimens. I consent to be contacted for future research studies related to this study.

Authorization Expiration Date

Voluntary Participation and Withdrawal

Voluntary Participation: Your participation is voluntary. You may withdraw from the study at any time without penalty or loss of benefits to which you are otherwise entitled. Withdrawal will not affect your access to medical care.

If you withdraw, the investigator may retain and use data and specimens collected prior to withdrawal as noted in the consent and in accordance with applicable law and institutional policy.

Contact for Questions or Injury

Study Contact Name Study Contact Phone / Email

Certification and Informed Consent

I have read (or had read to me) the information provided about this study, including the purpose, procedures, potential risks and benefits, alternatives, confidentiality protections, and my rights as a participant. I have had the opportunity to ask questions, and my questions have been answered to my satisfaction. I understand that participation is voluntary and that I may withdraw at any time.

By signing below I authorize the research team to collect my health information and, if I have consented above, biological samples for the purposes described. I understand the terms of compensation (if any) and who to contact for questions or in the event of a research-related injury.

If signed by legal representative or guardian, state relationship

Participant Name:

Signature:

Date:

What the Healthcare Clinical Trials Form Is

The Healthcare Clinical Trials Form documents a patient or participant's informed consent and related trial-specific data for participation in a clinical study. It typically combines participant identification, study details, risks and benefits disclosure, data use and privacy consents, emergency contact information, and signature blocks for the participant and responsible investigator. The form creates a permanent record used by sponsors, institutional review boards (IRBs), and regulators to confirm lawful and informed enrollment and to support safety reporting and audit trails.

Why a Proper Clinical Trials Form Matters

A complete, compliant form documents informed consent, protects participant rights, and supports regulatory reporting. Accurate forms reduce legal and operational risk, enable auditable processes for IRB reviews and sponsor oversight, and ensure privacy safeguards required under HIPAA and other laws.

Who Typically Prepares and Signs This Form

Research teams, clinical coordinators, study sponsors, and IRBs commonly prepare and manage clinical trials forms.

Principal investigators and delegated study staff completing enrollment and signature sections.
Study sponsors or CROs managing templates, version control, and central recordkeeping.
Institutional review boards (IRBs) approving language and retention instructions for consent.

Core Components of a Professional Clinical Trials Form

A well-structured form separates participant-facing sections from administrative fields, includes clear consent language, and provides audit-ready signature and witnessing elements to meet regulatory and ethical standards.

Study Summary

Brief protocol overview, objectives, and duration in plain language for participants.

Risks & Benefits

Concise description of foreseeable risks, potential benefits, and alternative options.

Data Use

Details on data collection, storage, de-identification, and sharing with third parties.

HIPAA/Privacy

Patient authorization language and any required HIPAA disclosure or BAA references.

Signatures

Participant signature, date, investigator signature, and witness or notary fields if required.

Versioning

Form ID, effective date, and IRB approval number for audit and change control.

Step-by-Step: Filling Out the Clinical Trials Form

Follow these sequential steps to complete enrollment accurately and create an auditable consent record.

01

Review Materials: Read the participant information and protocol summary fully before consenting.
02

Confirm Eligibility: Verify inclusion/exclusion criteria and record screening results.
03

Complete Fields: Fill personal data, emergency contact, and study-specific entries.
04

Sign & Date: Participant and investigator sign; capture witness or notary if required.

Configuring the Form for Online Completion

Set up digital fields and authentication to preserve audit trails and meet privacy obligations when collecting e-consent.

Field	Configuration
Signature Fields	Require typed or drawn signature and timestamped audit entry.
Conditional Fields	Show follow-up questions only when applicable to participant responses.
Authentication	Use email link, SMS code, or stronger methods for identity verification.
File Attachments	Allow upload of signed assent forms or ID documents as PDF.

Technical and Platform Considerations

Choose a platform that supports secure storage, audit trails, and industry integrations to streamline clinical workflows.

Document Formats: Support for PDF, DOCX, and exportable audit logs.
Integrations: Connect with EDC, CRM, and cloud storage systems.
Compliance: HIPAA-ready configurations and BAA availability.

Ensure the chosen service records timestamps, IP addresses, and signer authentication evidence to support regulatory audits and IRB reviews.

Where Completed Forms Are Sent and Stored

Completed consents must follow sponsor and institutional routing to ensure oversight, safety reporting, and secure retention.

Sponsor / CRO: Central repository for trial documentation and monitoring.
Institutional Records: Site keeps master copy for local regulatory compliance.
IRB: Submit consent forms and any amendments for approval and audit.
ClinicalTrials.gov: Sponsor registers trial-level results and certain consent-related data where required.

Key Timelines and Reporting Deadlines

Track regulatory and study-specific deadlines to remain compliant for enrollment, safety reporting, and public disclosures.

IRB Approval Date:

Study activities must not start before IRB approval and effective consent versions.

Enrollment Window:

Adhere to protocol-defined enrollment start and stop dates for valid consent.

Adverse Event Reporting:

Report serious adverse events per protocol and regulatory timelines, often within 24–72 hours.

ClinicalTrials.gov Results:

Submit required results reports within the timeframe specified by law or sponsor policy.

Form Version Control:

Use IRB-approved form versions and archive superseded copies with version dates.

Required Information Elements

Participant ID: Unique study identifier

Full Name: Legal name as ID

Contact Details: Phone and address

DOB: MM/DD/YYYY format

Consent Date: Signed date entry

Investigator: Name and signature

Consequences of Incomplete or Incorrect Forms

Regulatory Action: IRB suspension or warning

Data Inadmissibility: Collected data may be unusable

Financial Penalties: Fines under applicable statutes

Legal Liability: Increased litigation risk

Participant Harm: Delayed safety response

Audits: Extended inspections and remediation

Common Mistakes to Avoid

Using an outdated IRB-approved version of the consent form or failing to document version control.
Collecting signatures without proper identity verification or skipping required witness/notary steps.
Missing or incomplete data fields such as DOB or emergency contact which impede follow-up.
Storing forms in unsecured locations or failing to retain an accessible audit trail for compliance.

Who May Sign on Behalf of the Sponsor or Site

Principal Investigator

The principal investigator signs to confirm they have explained the study and will oversee participant safety. As lead clinician, they certify eligibility checks and attest to ethical conduct and accurate recordkeeping required by the IRB.

Authorized Signatory

A designated site or sponsor representative may sign administrative acknowledgments or delegation logs. Their authority should be documented by delegation logs or a corporate resolution to confirm signatory power.

How Organizations Use Clinical Trials Forms in Practice

Real-world examples illustrate efficient e-consent and secure recordkeeping for clinical operations and audits.

Optica Ventures (COO)

Optica standardized digital consent for multi-site enrollment to reduce errors and timelines.

Rapid adoption across sites reduced turnaround time.
"The interface is simple and easy-to-use for our team; more importantly, it is just as easy for our customers."

Fertility Centers of Illinois (Founder)

The center implemented secure e-consent and API-based integration with EHR to centralize records.

Integration automated storage and retrieval for audits.
"The airSlate SignNow team has been exceptional, responsive, the API has been great, and we're extremely happy that we chose airSlate SignNow as a company."

eSignature Pricing and Feature Comparison

A neutral comparison of common eSignature vendor starting prices and core features relevant to clinical trial forms and HIPAA compliance.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	No	No	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently Asked Questions

Answers to common questions about legality, eConsent, authentication, and recordkeeping for clinical trials forms.

Need help? Contact support

Are electronic consents legally valid?
Yes. Electronic signatures are legally recognized under the federal ESIGN Act (15 U.S.C. §7001) and by state UETA statutes in most jurisdictions; ensure the signature shows intent, consent, attribution, and retention capability.
Do I need a HIPAA BAA for eConsent vendors?
If the vendor will access or store protected health information, execute a Business Associate Agreement as required by HIPAA; HIPAA policies and retention rules (45 CFR §164.530(j)) still apply.
What authentication is sufficient?
Authentication should match the risk: email link or SMS may be acceptable for low risk; consider stronger methods (KBA, multi-factor) for higher-risk studies or per IRB requirements.
Can forms be notarized remotely?
Remote notarization depends on state RON laws; many states permit RON with identity proofing and audio-video recording, but verify the state's notary rules before relying on RON for clinical consents.
How do I correct a signed form?
Do not alter a signed record. Create an addendum or corrected version with new signatures and date; retain the original for audit and note the reason for correction.
How long must signed consents be kept?
Retain consent forms for the life of the trial and follow federal and HIPAA retention rules; HIPAA requires 6 years (45 CFR §164.530(j)) and some sponsors or states require longer periods.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now